Related Experiment Video
Updated: Aug 7, 2026

Making MR Imaging Child's Play - Pediatric Neuroimaging Protocol, Guidelines and Procedure
Published on: July 30, 2009
Administration of oral chloral hydrate to paediatric patients undergoing magnetic resonance imaging
C L Ronchera1, L Martí-Bonmatí, C Poyatos
1Department of Pharmacy, Hospital Dr. Peset, Valencia, Spain.
Insights
Oral chloral hydrate effectively sedates pediatric patients for MRI scans, with higher doses improving success rates. A simple formula is proposed to optimize dosage based on age.
Area of Science:
- Pediatric Anesthesiology
- Radiology
- Pharmacology
Background:
- Sedation is essential for pediatric patients undergoing magnetic resonance imaging (MRI).
- Oral chloral hydrate is a commonly used sedative in pediatric practice.
Purpose of the Study:
- To assess the efficacy and safety of oral chloral hydrate for pediatric MRI sedation.
- To identify factors influencing sedation effectiveness and propose a dosing optimization method.
Main Methods:
- A prospective study involving 172 pediatric patients receiving oral chloral hydrate (70 mg/ml) 20-30 minutes before MRI.
- Dosage, patient age, weight, and diagnosis were recorded. Sedation effectiveness and adverse events were monitored.
Main Results:
- Effective sedation was achieved in 80.3% with initial doses and 93.6% with total doses.
- Higher doses (65 mg/kg) and younger age correlated with better sedation. Adverse reactions occurred in 4.7% of patients.
- A formula (mg/kg = age in months/2 + 50) was proposed for optimal dosing.
Conclusions:
- Oral chloral hydrate is an effective and safe option for pediatric MRI sedation.
- Dose optimization based on age is crucial for improving sedation success rates.
- The proposed simple dosing formula can aid clinicians in pediatric sedation management.
Abstract:
Sedation is frequently required in children undergoing magnetic resonance imaging (MRI). 172 Paediatric patients (82 female and 90 male, age 42 +/- 26 months, weight 14.7 +/- 5.6 kg) entered an open, non-comparative, prospective study to assess the utilization of oral chloral hydrate. Chloral hydrate syrup (70 mg/ml) was administered 20-30 min prior to the procedure. Effective sedation was reached in 80.3% with an average initial dose of 55 mg/kg and in 93.6% with an average total dose of 65 mg/kg. Significant differences in effectivity were correlated with the dose (54 +/- 11 mg/kg in failure cases versus 66 +/- 16 mg/kg in effective cases; p < 0.05) and diagnosis (effectivity falls to 62.5% and 76.0% in children with medullar tumours and encephalic white matter alterations, respectively; p < 0.01). Average sleep induction time was 30 +/- 19 min, and average duration of sleep was 62 +/- 24 min. Adverse reactions occurred in 4.7%, with nausea, vomiting and stomach pain being the most common side-effects (3.5%). Multivariate statistical analysis selects total dose and age into the discriminant function, with a 100% relative percentage of correct classification. A simple method for optimizing the chloral hydrate dose in children is proposed: the dose in mg/kg is calculated as half the age in months + 50.
Related Concept Videos
Magnetic Resonance Imaging
Skeletal Muscle Relaxants: Therapeutic Uses
Radiological Investigation I: X-ray and CT
Imaging Studies I: CT and MRI
Description of the Procedures
Computed Tomography (CT) scan:
Computed Tomography (CT) scans use X-ray technology to generate detailed images of bones, organs, and tissues. During the scan, the patient lies on a moving table...
Imaging Studies for Cardiovascular System IV: CMRI
Imaging Studies IV: Magnetic Resonance Imaging

